Catherine Gutierrez Moore

6PUBLICATIONS
32CO-AUTHORS
Haematological tumoursPredictive and prognostic markersData qualityLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.

|Feb 17, 2025
Treatment of Relapsed/Refractory AML-Novel Treatment Options Including Immunotherapy.

Catherine Gutierrez Moore, Anthony Stein, Amir T Fathi

|Jan 30, 2023
The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States.

Catherine Gutierrez, Shuji Ogino, Jeffrey A Meyerhardt

|Apr 23, 2022
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

J Bryan Iorgulescu, Chuxuan Sun, Corey Neff

|Dec 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment.

Catherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner

|Oct 23, 2021
Activation of Notch and Myc Signaling via B-cell-Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia.

Anat Biran, Shanye Yin, Helene Kretzmer

Pageof 1

Frequent Collaborators

2 joint publications

Donna S Neuberg

2 joint publications

Anthony Letai

2 joint publications

Catherine J Wu

2 joint publications

J Bryan Iorgulescu